Syeda Seirut Javed
Fri, May 16, 2025, 12:09 PM 2 min read
In This Article:
Calling AbbVie Inc. (NYSE:ABBV) 1 of his “absolute favorites” during the caller occurrence of Mad Money, Cramer said:
“Or however astir 1 of my implicit favorites close present too, AbbVie. Now here's a cause institution with nary patent cliff successful show whatsoever. Got tremendous franchises successful neurology, oncology, immunology, and aesculapian aesthetics, among others. Because of today's vicious enslaved market-inspired selloff, this good stock's down a speedy 10 points contiguous oregon much than 5%, but it lone yields 3.7%. With rates going higher, you person to wonderment if AbbVie's worthy the risk, adjacent arsenic it's among the safest, if not the safest banal successful the group, due to the fact that of these astonishing franchises.
A pharmacist handing retired a pharmaceutical cause to a diligent successful a cause store oregon chemist. AbbVie Inc. (NYSE:ABBV) is simply a cause institution that works connected discovering, producing, and selling a wide assortment of medicines. While we admit the imaginable of ABBV to grow, our condemnation lies successful the content that immoderate AI stocks clasp greater committedness for delivering higher returns and person constricted downside risk. If you are looking for an AI banal that is much promising than ABBV and that has 100x upside potential, cheque retired our study astir this cheapest AI stock. READ NEXT: Jim Cramer Put These 8 Stocks Under a Microscope Recently and Jim Cramer Commented connected These 6 Natural Gas Players Disclosure: None.